ArticlePathology oncology research : POR2020

Unraveling LGALS1 as a Potential Immune Checkpoint and a Predictor of the Response to Anti-PD1 Therapy in Clear Cell Renal Carcinoma.

Yan Li et al.PubMed ↗Publisher ↗

No numbers read from the abstract.